Last Posted: Jun-07-2023 06:32:38
Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNet.
Emily A Smith et al. Microb Genom 2023 6 (6)
Why the world needs more transparency on the origins of novel pathogens
M Venter, Nature, May 30, 2023
Assessing the potential of polygenic scores to strengthen medical risk prediction models of COVID-19.
Aldo Córdova-Palomera et al. PLoS One 2023 5 (5) e0285991
Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program.
M Daniel Brannock et al. Nat Commun 2023 5 (1) 2914
Knafou Julien, et al. Systematic reviews 2023 0 0. (1) 94
The Implications of Using Digital Technologies in the Management of COVID-19: Comparative Study of Japan and South Korea.
Yang Sou Hee, et al. Journal of medical Internet research 2023 0 0. e45705
Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteins.
Broly Hervé, et al. mAbs 2023 0 0. (1) 2220150
Severe acute respiratory syndrome coronavirus-2 antibody response after Moderna vaccine booster on healthcare providers.
Fachrucha Fanny, et al. Journal of infection in developing countries 2023 0 0. (5) 617-622
Development and validation of a novel CD4 T cell-related gene signature to detect severe COVID-19.
Zhang Da-Wei, et al. Clinical and translational medicine 2023 0 0. (6) e1294
Identification and characterization of 7-azaindole derivatives as inhibitors of the SARS-CoV-2 spike-hACE2 protein interaction.
Wang Chaojie, et al. International journal of biological macromolecules 2023 0 0. 125182
Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2.
Heydemann Laura, et al. Nature communications 2023 0 0. (1) 3267
Has COVID-19 changed the spectrum of arrhythmias and the incidence of sudden cardiac death?
Kuck Karl-Heinz, et al. Herz 2023 0 0. 1-6
LAPIS is a fast web API for massive open virus sequencing data.
Chen Chaoran, et al. BMC bioinformatics 2023 0 0. (1) 232
Pre-assessment and management of long COVID patients requiring elective surgery: challenges and guidance.
Boles Sophie, et al. Perioperative medicine (London, England) 2023 0 0. (1) 20
About COVID-19 GPH
Wei Yu, et al. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Sign up Email Alert
In PHGKB Databases
Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations and response to COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science, digital health, machine learning and predictive analytic methods (not involving genomics) in discovery, clinical and public health investigations and response to COVID-19
Following categories are annotated by LitCovid from NCBI NIH.
|Mechanism||Underlying cause(s) of covid-19 infections and transmission & possible drug mechanism of action|
|Transmission||Characteristics and modes of covid-19 transmissions, such as human-to-human|
|Diagnosis||Disease assessment through symptoms, test results, and radiological features|
|Prevention||Prevention, control, response and management strategies|
|Case Report||Descriptions of specific patient cases|
|Forecasting||Modelling and estimating the trend of covid-19 spread|
|Health Equity||Relevant to health equity. Search terms are derived from a list provided by the Association for Territorial Health Officials which include terms such as diversity, health disparities, and others.|
|Vaccine||Relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages|
|Variant||Relevant to SARS-CoV-2 variants and their impact on public health. For additional information on variants COVID-19. Check out CDC New Variants of the Virus that Causes COVID-19 page|
|Surveillance||Relevant to SARS-CoV-2 public health surveillance and tracking. For additional information on COVID-19 surveillance, check out CDC COVID-19 Data Tracker|
Wei Yu, Emily Drzymalla, Marta Gwinn and Muin J. Khoury. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Genomics and Precision Public Health to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 06, 2023
- Content source: